Press Releases Search Search Category Topic Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Institute & Campus (8) Press release (44) Science (8) 3R principles (replace, reduce, refine) (5) Allergies (7) Alternative methods to animal studies (5) Alzheimer (19) Amyotrophic lateral sclerosis (ALS) (2) Animal Research (40) Art (5) Artificial Intelligence (10) Bacteria (5) Basic Research (8) Berlin Science Week (7) BIH (20) BIMSB (61) Biochemistry & Proteomics (18) Brain Tumor (11) Breast Cancer (7) Campus (2) Campus Buch (7) Campus Life (6) Cancer (89) Cardiovascular Research (81) Career (2) Cell Biology (37) Charité (33) Chorea Huntington (11) Clinical Research (11) Clinical Studies (4) Communication (3) Computational Biology (8) Construction (3) Corona Research (7) CRISPR/Cas9 (20) Data science (10) Developmental Biology (10) Diabetes (21) Disease-related Research (66) DZHK (16) (-) ECRC (29) Epidemiology (4) ERC (15) EU-Life (5) FMP (5) Gene Engineering (9) Gene Expression Regulation & RNA Biology (33) Genetics & Genomics (56) Green Campus (1) Helmholtz (2) High-throughput technologies (7) History (6) Hypertension (42) Imaging (12) Immunology (39) (-) Immunotherapy (13) Induced pluripotent stem cells (iPSCs) (7) (-) Institute (13) Knowledge transfer (14) Labor trifft Lehrer (2) Life Science Learning Lab (1) LifeTime (9) Long Night of Sciences (1) Lung Cancer (1) Lymphoma (22) MDC-Forschung (5) Metabolism (11) Microbiome (1) Multiple sclerosis (2) Muscular dystrophy (9) NAKO (6) Neuroscience (79) Open Access (1) OpenScience (9) Organoids (17) Pain (2) Personalia (68) Pharmacology (1) PhD Students (4) Physiology (4) (-) Postdocs (3) Research Highlights (44) Responsible Research (6) science policy (4) Signal Transduction (25) Single-cell analysis (37) Stem Cell Biology (30) Structural Biology & Biophysics (8) Support for Scientists (2) Systems Biology (20) Teachers & Pupils (3) Technology Platforms (5) Technology Transfer (5) Titin (7) Translation (8) We at the MDC (1) Women in Science (2) Work and Family (3) 56 Results: Active Filter: ECRCImmunotherapyInstitutePostdocs Sort: Result score Newest to oldest Oldest to newest Press Release No. 3 January 26, 2021 Berlin Lord of the rings Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A publication in the scientific journal Nature Genetics was decisive for this award. Press Release No. 1 January 11, 2021 Berlin A potent weapon against lymphomas MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic lymphocytic leukemia, the most common type of blood cancer in adults. Press Release No. 59 December 28, 2020 Berlin Integration of BIH into Charité and the privileged partnership with the MDC On January 1, 2021, the Berlin Institute of Health (BIH ) has become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar. Press Release No. 51 November 05, 2020 Berlin The ebb and flow of brain ventricles Enlarged ventricles in the brains of people with multiple sclerosis were previously considered a sign of tissue loss. But a team at the MDC and ECRC demonstrated that this expansion often recedes. A study published in JCI Insight now shows that the process observed in mice is transferable to humans. Press Release No. 34 August 14, 2020 Berlin €66 million for the Berlin spin-off T-knife The Berlin biotech start-up T-knife, a spin-off from the MDC together with Charité, has secured investments totaling €66 million. Four venture capital funds committed to the financing in early August. T-knife develops new cancer treatments using modified immune system T cells. Press Release No. 25 June 11, 2020 Berlin Overactive enzyme causes hereditary hypertension After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure. This could lead to new concepts for the treatment of hypertension. Press Release No. 21 April 30, 2020 Berlin Support for SARS-CoV-2 diagnostics The LabHive digital platform aims to provide necessary resources to diagnostic centres to enable more tests for SARS-CoV-2. Tobias Opialla from the MDC is one of 15 volunteers who has been involved in the project since the #WirvsVirus Hackathon organized by the German government. Press Release No. 20 April 27, 2020 Berlin A potential agent for treating preeclampsia Researchers at the ECRC have successfully used RNA molecules to treat a dangerous pregnancy disorder called preeclampsia. They were able to alleviate common symptoms of the disorder, like maternal high blood pressure and fetal undernutrition, with virtually no side effects. Press Release No. 17 April 20, 2020 Berlin New therapeutic options for multiple sclerosis in sight Strategies for treating multiple sclerosis have so far focused primarily on T and B cells. A group of MDC researchers has now unveiled a new approach in Nature Immunology – one that seeks to increase treatment effectiveness by selectively targeting another type of immune cell called monocytes. Press Release No. 15 April 08, 2020 Berlin Millions for cancer research Thomas Blankenstein receives an ERC Advanced grant for cancer research. The scientist wants to find out if T cells control the development of cancer by a process called immunosurveillance. For this purpose he now proposes a new research model. Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
Press Release No. 3 January 26, 2021 Berlin Lord of the rings Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A publication in the scientific journal Nature Genetics was decisive for this award.
Press Release No. 1 January 11, 2021 Berlin A potent weapon against lymphomas MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic lymphocytic leukemia, the most common type of blood cancer in adults.
Press Release No. 59 December 28, 2020 Berlin Integration of BIH into Charité and the privileged partnership with the MDC On January 1, 2021, the Berlin Institute of Health (BIH ) has become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar.
Press Release No. 51 November 05, 2020 Berlin The ebb and flow of brain ventricles Enlarged ventricles in the brains of people with multiple sclerosis were previously considered a sign of tissue loss. But a team at the MDC and ECRC demonstrated that this expansion often recedes. A study published in JCI Insight now shows that the process observed in mice is transferable to humans.
Press Release No. 34 August 14, 2020 Berlin €66 million for the Berlin spin-off T-knife The Berlin biotech start-up T-knife, a spin-off from the MDC together with Charité, has secured investments totaling €66 million. Four venture capital funds committed to the financing in early August. T-knife develops new cancer treatments using modified immune system T cells.
Press Release No. 25 June 11, 2020 Berlin Overactive enzyme causes hereditary hypertension After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure. This could lead to new concepts for the treatment of hypertension.
Press Release No. 21 April 30, 2020 Berlin Support for SARS-CoV-2 diagnostics The LabHive digital platform aims to provide necessary resources to diagnostic centres to enable more tests for SARS-CoV-2. Tobias Opialla from the MDC is one of 15 volunteers who has been involved in the project since the #WirvsVirus Hackathon organized by the German government.
Press Release No. 20 April 27, 2020 Berlin A potential agent for treating preeclampsia Researchers at the ECRC have successfully used RNA molecules to treat a dangerous pregnancy disorder called preeclampsia. They were able to alleviate common symptoms of the disorder, like maternal high blood pressure and fetal undernutrition, with virtually no side effects.
Press Release No. 17 April 20, 2020 Berlin New therapeutic options for multiple sclerosis in sight Strategies for treating multiple sclerosis have so far focused primarily on T and B cells. A group of MDC researchers has now unveiled a new approach in Nature Immunology – one that seeks to increase treatment effectiveness by selectively targeting another type of immune cell called monocytes.
Press Release No. 15 April 08, 2020 Berlin Millions for cancer research Thomas Blankenstein receives an ERC Advanced grant for cancer research. The scientist wants to find out if T cells control the development of cancer by a process called immunosurveillance. For this purpose he now proposes a new research model.